Kenneth L. Marek

Internal Medicine
60 Temple St
New Haven, CT 06510

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 143 publications

Reply to: "What Does α-Syn-SAA-Negative Parkinson's Disease Reveal about the Proposed "Biological Definition" of Parkinson's Disease?"

Reply to: "What Does α-Syn-SAA-Negative Parkinson's Disease Reveal about the Proposed "Biological Definition" of Parkinson's Disease?"

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: July 07, 2026

Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined Synucleinopathy.

Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined Synucleinopathy.

Journal: Annals of clinical and translational neurology
Published: March 13, 2026

Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative.

Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative.

Journal: Annals of neurology
Published: March 11, 2026

Future Directions: The Parkinson's Precision Medicine Initiative.

Future Directions: The Parkinson's Precision Medicine Initiative.

Journal: Annals of neurology
Published: March 03, 2026

Cognitive Impairment in Parkinson's Disease: Contributions from the Parkinson's Progression Markers Initiative.

Cognitive Impairment in Parkinson's Disease: Contributions from the Parkinson's Progression Markers Initiative.

Journal: Annals of neurology
Published: February 26, 2026

From Parkinson's Progression Markers Initiative to Parkinson's Precision Medicine Initiative: Still PPMI.

From Parkinson's Progression Markers Initiative to Parkinson's Precision Medicine Initiative: Still PPMI.

Journal: Annals of neurology
Published: February 26, 2026

Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers Initiative.

Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers Initiative.

Journal: Annals of neurology
Published: February 17, 2026

Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative.

Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative.

Journal: Annals of neurology
Published: February 11, 2026

Insights Gained From the PPMI Brain Donation Program.

Insights Gained From the PPMI Brain Donation Program.

Journal: Annals of neurology
Published: February 09, 2026

How PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early-Stage Neuronal Alpha-Synuclein Disease.

How PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early-Stage Neuronal Alpha-Synuclein Disease.

Journal: Annals of neurology
Published: February 09, 2026

Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease.

Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease.

Journal: Annals of neurology
Published: February 06, 2026

Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMI.

Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMI.

Journal: Annals of neurology
Published: February 06, 2026
Showing 1-12 of 143

Last Updated: 09/26/2026